NAMED PATIENT PROCESS (NPP)
OrphanDC provides patients and physicians, in Brazil & Argentina, with the opportunity to access medicines, commercially approved abroad, in their own country. Named Patient Process, aka Named Patient Sale is viable and a soft-landing opportunity in both territories.
PARTICULARITIES IN BRAZIL & ARGENTINA
9 to 12 months market access prediction
75% predicted market acceptance
2 to 3 months market access prediction
90% predicted market acceptance